O-Health, an Indian health technology startup, has secured strategic funding to grow its clinical AI platform and hardware business. The investment amount has not been disclosed, but the purpose is clear – the company wants to build tools that can help hospitals collect patient information faster while keeping sensitive data closer to the point of care.

The funding round comes at a time when hospitals are looking for practical technology, not just flashy software. O-Health is betting that AI tools placed inside hospitals and clinics can reduce routine work for doctors and help patients move through the early stages of a consultation more smoothly.

Who is behind O-Health

O-Health was founded by Arunoday Singh and Akshar KR. Singh is the company’s CEO and has a background in healthcare delivery, while Akshar KR is linked to the technical side of the platform. The company’s founding year has not been publicly disclosed in the recent funding reports.

The startup began with a focus on bringing digital healthcare support to underserved areas. Over time, it has expanded its work towards voice-led clinical tools that can be used in hospitals and clinics.

According to reports, the latest funding round includes Dr Sangita Reddy, Joint Managing Director of Apollo Hospitals, Singapore-based BugleRock Capital, Perpetual Capital, ACKO co-founder Varun Dua, Curefoods co-founder Ankit Nagori and other investors.

What O-Health actually builds

O-Health has developed a voice-first patient assessment platform. In simple terms, it is designed to listen to a patient’s answers, ask relevant follow-up questions and turn that conversation into a structured summary for the doctor.

For example, a patient visiting a clinic with fever, cough and body pain may first speak to an O-Health system. It can record the key symptoms and organize the details before the doctor begins the consultation. The doctor can then spend less time gathering basic information and more time examining the patient.

The startup says its technology runs on its own clinical hardware. This is where “edge AI” becomes important. Instead of sending all information to a distant cloud server for processing, the system works on devices placed inside the healthcare facility.

That approach may help in places where internet connectivity is weak or unreliable. It can also give hospitals more control over where patient information is processed.

Where the new funding will be used

O-Health plans to use the fresh capital for product engineering, edge AI model development and clinical hardware. It also aims to prepare its devices for wider manufacturing and expand into more healthcare areas.

The company has said it wants to move beyond outpatient pre-assessment. Its future plans include connected clinical devices, patient monitoring tools, preventive health technology and systems that can support hospital workflows.

This is an ambitious plan, but it makes business sense. A hospital may be more likely to use one connected platform across several tasks than separate tools for patient intake, monitoring and clinical notes.

The funding is also expected to support expansion across public and private healthcare institutions. O-Health has reportedly completed over 50,000 clinical consultations and has deployments that include Yashoda Medicity in Delhi NCR.

Competition and the road ahead

O-Health is entering a growing health technology market where hospitals have many choices. Companies such as Eko Health, known for AI-supported digital stethoscopes, show how clinical hardware and software can work together. However, O-Health’s focus is different. It is building tools around patient conversations, pre-assessment and local AI processing for Indian healthcare settings.

Its real test will be adoption. Hospitals will look at whether the system saves staff time, works accurately across accents and languages, protects patient data and fits into existing routines.